Brind.

DataMeds AI Acquires Cancer Diagnostics Assets from Todos Medical

2 reports, 1 independent Updated Fri 00:30
No new developments lately Reached 2 outlets in its first 24 hours
Reports
2
Developments
1
Repetition
50%

New informationRepeats or wire copies

AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

DataMeds AI agreed to acquire certain assets from the estate of Todos Medical Ltd. These assets include Cancer AI Total Biochemical Infrared Analysis blood tests for breast and colorectal cancer. The platform utilizes Fourier-transform infrared spectroscopy biochemical analysis of blood plasma. The acquired tests hold CE Marks in Europe and have issued patents in the U.S. and Europe.

From timesargus.com

Why it matters

Some supportBrind's analysis of the reports

The acquisition provides DataMeds AI with proprietary diagnostic technology, including US patents offering exclusivity until at least 2034. The company plans to use the platform, which will be transferred to Helomics, to revalidate data before seeking FDA approval.

From timesargus.com

Who's involved

  • Todos MedicalThe company whose estate provided the cancer diagnostics assets
  • GRAILA competitor in the American biotechnology and pharmaceutical sector

Who could feel it

Possible knock-on effects

These are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.

  • GRAILSpeculative

    GRAIL might face increased competition in the cancer diagnostic market, potentially affecting sales.

  • The European Medicines Agency may increase regulatory oversight of the diagnostic platform in Europe, affecting compliance costs.

  • NasdaqSpeculative

    Nasdaq could see increased market confidence in DataMeds AI due to the acquisition of patented assets, potentially affecting investment valuation.

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped
1 more outlet ran the same wire story